Invictus MD Strategies (Invictus MD Strategies) Cash, Cash Equivalents, Marketable Securities : $0.80 Mil (As of Oct. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Cash, Cash Equivalents, Marketable Securities?

Invictus MD Strategies's quarterly cash, cash equivalents, marketable securities declined from Apr. 2019 ($2.61 Mil) to Jul. 2019 ($1.27 Mil) but then stayed the same from Jul. 2019 ($1.27 Mil) to Oct. 2019 ($0.80 Mil).

Invictus MD Strategies's annual cash, cash equivalents, marketable securities increased from Jan. 2017 ($2.63 Mil) to Jan. 2018 ($30.25 Mil) but then declined from Jan. 2018 ($30.25 Mil) to Jan. 2019 ($7.39 Mil).

Invictus MD Strategies Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Invictus MD Strategies's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Cash, Cash Equivalents, Marketable Securities Chart

Invictus MD Strategies Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Cash, Cash Equivalents, Marketable Securities

0.29

0.17

2.63

30.25

7.39

Invictus MD Strategies Quarterly Data
	Jan15	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															18.28	7.39	2.61	1.27	0.80

Invictus MD Strategies Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Invictus MD Strategies (OTCPK:IVITF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Invictus MD Strategies Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Invictus MD Strategies (Invictus MD Strategies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1

Website

http://www.invictus-md.com

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.